RAPT Therapeutics Inc

NASDAQ:RAPT  
30.06
-2.15 (-6.68%)
Earnings Announcements

RAPT Therapeutics Reports Q3 2021 Financial Results

Published: 11/10/2021 22:23 GMT
RAPT Therapeutics Inc (RAPT) - Rapt Therapeutics Reports Third Quarter 2021 Financial Results.
Rapt Therapeutics Inc - Qtrly Loss per Share $0.63.
Revenue is expected to be $0.63 Million
Adjusted EPS is expected to be -$0.65

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.75

More details on our Analysts Page.